Avon Foundation for Women Awards More Than $4.3 Million in Grants in 2Q 2013 to Breast Cancer Organizations

Total Includes More Than $2.75 Million for Breast Cancer Prevention and Detection Research


New York, NY, June 13, 2013 – The Avon Foundation for Women has awarded more than $4.3 million in new grants to support 17 breast cancer organizations in the United States and Canada during the second quarter of 2013, including more than $2.75 million in funding for breast cancer prevention and detection research.

Since its launch in 1993, the Avon Breast Cancer Crusade has donated more than $780 million in 58 countries to leading cancer centers and community-based breast health programs focusing in three areas: scientific research, access to care programs for the medically underserved and outreach programs focused on education and screening. As a direct result of these programs in the U.S., more than three million women have received free mammograms and breast cancer screenings since 2000 and more than 12 million women have been educated about breast cancer and the importance of early detection to date.

The following Avon Breast Cancer Crusade grants were awarded at the Avon Walks for Breast Cancer in Boston and Chicago in Q2:

Avon Foundation Breast Cancer Research Programs
In its continuing support of scientific research into the causes of breast cancer, as well as its prevention and detection, the Avon Foundation has awarded more than $2.75 million to the following breast cancer research programs to fund new preventive strategies and treatments for breast cancer:

• Beth Israel Deaconess Medical Center Inc. (Boston), to continue researching the effects of the Epstein Barr Virus (EBV) infection on breast tissue.

• BIOARRAY Therapeutics Inc. (Farmington, Conn.), to develop a diagnostic test that would predict the type of chemotherapy a specific breast cancer will respond to and which therapies would be ineffective.

• Dana-Farber Cancer Institute (Boston), to identify if viruses or bacteria are present in different types of breast cancer through the generation and analyses of large scale sequencing data from breast cancer samples.

• Massachusetts General Hospital Cancer Center (Boston), home of an Avon Foundation Breast Care Center of Excellence, to research the association between pregnancy and breast cancer risk.

• Mount Sinai Hospital (Toronto), in collaboration with Harvard Medical School, to investigate how viruses could affect healthy breast cells and give rise to breast cancer.

• The Robert H. Lurie Comprehensive Cancer Center at Northwestern University (Chicago), home of an Avon Foundation Breast Care Center of Excellence and the Avon Breast Cancer Research Laboratories, to identify new therapies to fight breast cancer and lower breast cancer risk.

• Silent Spring Institute (Newtown, Mass.), to look at the potential role of the environment in breast cancer development.

• The Center for Advancing Innovation (Leesbury, Va.), to evaluate the progress of 64 Avon Foundation-funded research projects working to develop new diagnostic tests for breast cancer.

• Tufts University School of Medicine (Boston), to study the interaction between environmental chemicals and breast cells in a unique, 3D model of human cells.

• Washington University (St. Louis), to develop a standardized diagnostic test that measures the growth of a breast cancer tumor and whether it will respond to treatment.

Avon Foundation Access to Care Programs
To support the Avon Safety Net access to care programs, the Avon Foundation awarded more than $1.5 million in grants to the following organizations and institutions to provide access to health care for uninsured, at-risk, low-income, and minority patients, as well as outreach focused on nutrition, education and screening:

• Community Servings (Jamaica Plain, Mass.)
• Hektoen Institute for Medical Research, John H. Stroger Jr. Hospital (Chicago)
• LifeSpan Foundation, LifeSpan Comprehensive Cancer Center (Providence, R.I.)
• Massachusetts General Hospital Cancer Center (Boston)
• Mercy Hospital and Medical Center (Chicago)
• Metropolitan Chicago Breast Cancer Task Force (Chicago)
• The Robert H. Lurie Comprehensive Cancer Center at Northwestern University (Chicago)
• Rush-Copley Foundation (Aurora, Ill.)
• Sinai Health System (Chicago)

About the Avon Foundation for Women
The Avon Foundation for Women, the world’s largest corporate-affiliated philanthropy focused on issues that matter most to women, was founded in 1955 to improve the lives of women. Through 2012, Avon global philanthropy, led by the Avon Foundation, has donated more than $910 million in more than 50 countries for causes most important to women. Today, Avon philanthropy focuses on funding breast cancer research and access to care through the Avon Breast Cancer Crusade, and efforts to reduce domestic and gender violence through its Speak Out Against Domestic Violence program. Visit www.avonfoundation.org for more information.